SCM
CBPO

Segantii Capital Management’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Segantii Capital Management’s Portfolio CBPO Stock Details CBPO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-50,000
Closed -$5.29M – 79
2016
Q2 		$5.29M Buy
+50,000
New +$5.81M 5.8% 6

Other funds holding CBPO

WP
Warburg Pincus New York $343M AUM 18.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Segantii Capital Management's CBPO Position: Q3 2016 in Review

Segantii Capital Management sold out of China Biologic Products Holdings, Inc. (CBPO) in Q3 2016, closing a stake of 50,000 shares — an estimated $5.29M sold.

Segantii Capital Management first reported a position in CBPO in Q2 2016 and held it in 1 quarter. The position peaked at $5.29M in Q2 2016. 162 funds tracked by Wall St. Rank hold CBPO as of Q3 2016.

  • Segantii Capital Management reported no remaining China Biologic Products Holdings, Inc. position as of Q3 2016 after selling out during the quarter.
  • Segantii Capital Management sold 50,000 China Biologic Products Holdings, Inc. shares in Q3 2016, an estimated $5.29M.
  • Segantii Capital Management first reported a position in China Biologic Products Holdings, Inc. in Q2 2016 and held it in 1 quarter.
  • Segantii Capital Management's China Biologic Products Holdings, Inc. position peaked at $5.29M in Q2 2016.
  • 162 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q3 2016.

Based on Segantii Capital Management's 13F filing for Q3 2016, filed 9 Nov 2016.